Bowel Cancer - Rapid genomic profiling of colon cancers can improve therapy
Can't see this email? View it online
   
  Bowel Cancer  
  The latest bowel cancer news from News Medical  
 Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cellsNanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells
 
A novel toxin-based nanoparticle drug specifically is designed to attack colorectal cancer stem cells with overexpression of the chemokine receptor CXCR4.
 
   Rapid genomic profiling of colon cancers can improve therapyRapid genomic profiling of colon cancers can improve therapy
 
Genomic mutation testing is critical to the therapeutic selection and management of patients with colorectal cancer.
 
   Study reveals key biochemical processes that advance understanding of colorectal cancerStudy reveals key biochemical processes that advance understanding of colorectal cancer
 
A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs. A McGill-led study reveals key biochemical processes that advance our understanding of colorectal cancer, the third most common cancer among Canadians.
 
 Chronic inflammation disrupts tissue structure of the colon, study finds
 
Chronic inflammation disrupts tissue structure of the colon, study findsIn a new study, researchers have compared diseased colon with healthy tissue to better understand how inflammatory bowel disease (IBD) is linked to an increased risk of colorectal cancers, at a molecular level.
 
 
 Vitamin D shows promise to alleviate side effects of chemotherapy
 
Vitamin D shows promise to alleviate side effects of chemotherapyAs many cancer patients will confirm, the chemotherapy prescribed to kill the disease is often more debilitating than the cancer itself, with a range of horrendous side effects.
 
 
 Abnormal expression of Zeb2 protein in epithelial cells can induce colorectal cancer
 
Abnormal expression of Zeb2 protein in epithelial cells can induce colorectal cancerA collaborative study by research groups from the VIB-UGent Center for Inflammation Research and Ghent University uncovered a new mechanism causing colorectal cancer.
 
 
 Study: Hypertension medications can also reduce risk of colorectal cancer
 
Study: Hypertension medications can also reduce risk of colorectal cancerMedications commonly prescribed to treat high blood pressure may also reduce patients' colorectal cancer risk, according to new research published today in Hypertension, an American Heart Association journal.